Author/Authors :
Amini, Zahra Department of Biostatistics - School of Allied Medical Sciences - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Shakeri, Nezhat Department of Biostatistics - School of Allied Medical Sciences - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Amini, Mohammad Radiation Biology Research Center - Iran University of Medical Sciences, Tehran, Iran , Mokaberinejad, Roshanak Department of Traditional Medicine - School of Traditional Medicine - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Hasheminasab, Fatemeh Sadat Pharmacology Research Center - Zahedan University of Medical Sciences, Zahedan, Iran , Azimi, Maryam Department of Traditional Medicine - School of Persian Medicine - Kerman University of Medical Sciences, Kerman, Iran , Ghasemi, Saeedeh Shahid Mofateh Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Farokhi, Azam Shahid Mofateh Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Coronavirus disease 2019 (COVID-19) has a ected the lives of people all over the world. Although researchers are working to manage and minimize the impact of the current COVID-19 pandemic, no definitive treatment method has been identified so far. The present clinical trial aimed to evaluate the survival of two groups of patients with COVID-19.
Methods: The statistical population of this prospective clinical trial included 70 patients hospitalized in the Mofatteh Hospital in Varamin, Iran, from 13 May to 10 July 2020. The intervention and control groups were compared using the Kaplan-Meier method and log-rank test.Results: Patients in the intervention group had a higher survival rate than the control group. Conclusion: Hordeum vulgare increased the survival of patients.
Keywords :
COVID-19 , Hordeum vulgare , Kaplan-Meier , Survival
